SMTI (Sanara MedTech) Total Liabilities: $62.3 Mil (As of Mar. 2026)

What is Sanara MedTech Total Liabilities?

Sanara MedTech SMTI +2.48% 72 Total Liabilities is $62.3 Mil as of Mar. 2026. GuruFocus rates SMTI with a GF Score™ of 72/100 and a GF Value™ of $45.63 (Possible Value Trap). The stock has 6 warning signs investors should review.

Sanara MedTech's Total Liabilities for the quarter that ended in Mar. 2026 was $62.3 Mil.

Sanara MedTech's quarterly Total Liabilities increased from Sep. 2025 ($64.95 Mil) to Dec. 2025 ($67.01 Mil) but then declined from Dec. 2025 ($67.01 Mil) to Mar. 2026 ($62.26 Mil).

Sanara MedTech's annual Total Liabilities increased from Dec. 2023 ($29.28 Mil) to Dec. 2024 ($49.18 Mil) and increased from Dec. 2024 ($49.18 Mil) to Dec. 2025 ($67.01 Mil).

Sanara MedTech Total Liabilities Related Terms

Sanara MedTech Total Liabilities Historical Data

* Premium members only.

The historical data trend for Sanara MedTech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanara MedTech Total Liabilities Chart

Sanara MedTech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Liabilities

Get a 7-Day Free Trial

6.24

19.32

29.28

49.18

67.01

Sanara MedTech Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Liabilities	Get a 7-Day Free Trial															59.71	63.38	64.95	67.01	62.26

72GF Score

Sanara MedTech Inc SMTI

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Sanara MedTech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sanara MedTech's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	18.627	+	(47.84	+	0.547
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	67.0

Total Liabilities	=	Total Assets (A: Dec. 2025 )	-	Total Equity (A: Dec. 2025 )
	=	72.944	-	5.93
	=	67.0

Sanara MedTech's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	13.701	+	(47.997	+	0.56
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	62.3

Total Liabilities	=	Total Assets (Q: Mar. 2026 )	-	Total Equity (Q: Mar. 2026 )
	=	69.277	-	7.019
	=	62.3

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of $62.3 Mil mean?

Sanara MedTech (SMTI) has a Total Liabilities of $62.3 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sanara MedTech and its competitors.

Is Sanara MedTech's Total Liabilities too high?

Sanara MedTech's current Total Liabilities is $62.3 Mil. Overall, Sanara MedTech has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Sanara MedTech's Total Liabilities compare to EMBC and KRMD?

Sanara MedTech's Total Liabilities of $62.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Medical Devices & Instruments company?

A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sanara MedTech and its competitors. Sanara MedTech's current Total Liabilities is $62.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sanara MedTech stock overvalued right now?

Based on GuruFocus' analysis, Sanara MedTech (SMTI) is currently considered Possible Value Trap. The stock's GF Value™ is $45.63, compared to a current price of $24.85 — trading 45.5% below its estimated fair value. The current Total Liabilities is $62.3 Mil. Sanara MedTech's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For Sanara MedTech (SMTI), the current Total Liabilities is $62.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sanara MedTech (SMTI) Overvalued in 2026?

Based on GuruFocus' analysis, Sanara MedTech stock appears to be undervalued. The current stock price of $24.85 is trading 45.5% below its estimated GF Value™ of $45.63. GuruFocus considers Sanara MedTech to be Possible Value Trap.

Key valuation signals for SMTI:

Total Liabilities: $62.3 Mil
GF Value™: $45.63 vs. price of $24.85 (45.5% below fair value)
GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the SMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sanara MedTech Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies EMBC KRMD UTMD PDEX STXS OSUR MBOT POCI DXR NEPH ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST XSWX:STMN TSE:4543

Address 1200 Summit Avenue, Suite 414, Fort Worth, TX, USA, 76102

Website https://www.sanaramedtech.com

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

72GF Score

Get the complete analysis for SMTI

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.85

Price

$45.63

GF Value

View SMTI Analysis

See Total Liabilities data for all stocks →